$33m prizes for research
February 22, 2013Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google
Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …
Digital Pharma: what should we talk about?
October 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter
The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …
Boehringer beta launches Syrum on Facebook
September 17, 2012Medical Communications, Sales and Marketing Boehringer, Facebook, Syrum
Boehringer Ingelheim has announced the beta launch of its first social game on Facebook, the eagerly-awaited Syrum. Other sectors have …
Boehringer’s Syrum Facebook game launch date released
August 22, 2012Medical Communications Boehringer, Facebook, Syrum
Boehringer Ingelheim has announced the launch date of its social media game Syrum. John Pugh, Boehringer’s director of digital communications …
Microsoft buys Yammer for $1.2 billion
June 28, 2012Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network
Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …
Gamification and online communities – what can pharma do?
May 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing
Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …
GMC to create guidance on doctors’ use of social media
April 23, 2012Medical Communications BMA, Facebook, GMC, Twitter, social media
The General Medical Council is creating new draft guidance about what it expects from doctors when they are using social …
1 in 3 surveyed says social media changes attitudes to medicines
April 20, 2012Business Services, Medical Communications, Sales and Marketing Facebook, Twitter, digital, pwC, social networking
A third of US social media users say it could change the way they think about their medicines, according to …
Janssen to remove its Psoriasis 360 Facebook page
March 28, 2012Medical Communications Facebook, Janssen, PM Soc, Psoriasis 360
Janssen has decided to take down its award-winning Psoriasis 360 page on Facebook, citing an increasing amount of troublesome comments. …
FDA: don’t broadcast discussion on off-label uses
January 6, 2012Medical Communications FDA, Facebook, Twitter, off label, social media
The FDA has released long-awaited guidance for pharma firms about social media use. The FDA held a two-day public hearing …
Europeans keen on medicines info – but not via Facebook or Twitter
December 8, 2011Medical Communications Digital Blog, Facebook
A new survey finds demand for information on medicines is strong in Europe, but consumers aren’t using social sites such …
Merck and Merck look to settle Facebook naming dispute
November 29, 2011Medical Communications Facebook, Merck, Merck KGaA
Merck & Co and Merck KGaA looked to have made inroads into their Facebook naming quarrel. Earlier this month Merck …
Boehringer developing Facebook game
November 15, 2011Medical Communications Boehringer Ingelheim, Facebook
Boehringer Ingelheim is developing a new Facebook civilisation game in the hopes of helping the public understand the difficulty involved …
Digital Pharma: Lilly plans social media expansion
September 14, 2011Medical Communications Digital Pharma blog, Facebook, lilly, social media, youtube
One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …
Digital Pharma: Pharma adapts to new era on Facebook
August 15, 2011Medical Communications Digital Pharma blog, Facebook
Pharma companies must adapt to a new level of engagement on Facebook after new rules from the social network forcing …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
